Home / Resource Library / Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma

Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma

Study examined reasons for early disease progression in patients with DLBCL treated with CAR-T therapy.